Farag Kameel D. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Farag Kameel D. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $10K.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-26AKTXAkari Therapeutics PlcA — Grant or award1.0K$13.00$13K
2026-06-26AKTXAkari Therapeutics PlcA — Grant or award7.4K$3.74$28K
2026-06-26AKTXAkari Therapeutics PlcA — Grant or award3.7K$3.49$13K
2026-06-26AKTXAkari Therapeutics PlcA — Grant or award2.5K$5.12$13K
2026-06-26AKTXAkari Therapeutics PlcA — Grant or award1.6K$8.28$13K
2026-06-26AKTXAkari Therapeutics PlcA — Grant or award1.4K$9.32$13K
2026-06-26AKTXAkari Therapeutics PlcA — Grant or award1.2K$10.02$13K
2025-11-04AKTXAkari Therapeutics PlcA — Grant or award26.6K$0.75$20K
2025-11-04AKTXAkari Therapeutics PlcA — Grant or award32.0K$0.75$24K
2025-10-24AKTXAkari Therapeutics PlcA — Grant or award6.3K$0.74$5K

Companies — Last 90 Days

Frequently Asked Questions

Who is Farag Kameel D.?

Farag Kameel D. is a corporate insider — currently tracked as Interim CFO of Akari Therapeutics Plc (AKTX). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Farag Kameel D. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Farag Kameel D. been buying or selling stock?

Recorded transactions: 2 open-market purchases ($10K) and 0 open-market sales () across all tracked filings.

Where can I see all of Farag Kameel D.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Farag Kameel D. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.